Skip to content

Using mindfulness-based cognitive therapy to reduce anxiety symptoms among individuals diagnosed with substance use disorder

Mohannad A. Aldiqs, Ayman M. Hamdan-Mansour, Afaf Nowwara, B. Alhusamiah, Younis H. Abuhashish, N. Amer

Advances in Dual Diagnosis March 20, 2025 DOI: 10.1108/add-09-2024-0028 (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Experimental pre-post design with one-month follow-up Peer reviewed
Sample size 34
Population Individuals diagnosed with substance use disorders who also endorsed anxiety symptoms on the GAD-7
Duration Six 90-minute sessions; one-month follow-up
Measures Generalized Anxiety Disorder-7 (GAD-7)
Topics Addiction Anxiety Meditation
Key findings The authors report that a brief six-session mindfulness-based cognitive intervention produced significant reductions in anxiety symptoms among individuals diagnosed with substance use disorders, based on repeated measures ANOVA across pre-test, post-test, and one-month follow-up. They argue the findings support the intervention's effectiveness and can inform future trials.

Abstract

This study aims to examine the effectiveness of a brief six-session version of the mindfulness-based cognitive intervention derived from the positive psychology approach to decrease the symptoms of anxiety among individuals diagnosed with substance use disorders (SUDs). An experimental research design with pre- and post-tests and a one-month follow-up were used. The study sample comprised 34 participants diagnosed with SUD who also endorsed anxiety symptoms on the Generalized Anxiety Disorder-7 (GAD-7). The participants experienced six 90-min sessions of training in mindfulness-based cognitive intervention. At the end of the training, the participants were again evaluated using the GAD-7 immediately after the intervention and one month after. Analysis of repeated measures ANOVA was used to analyze the data. The results of this study suggested that MBCIs demonstrated significant reductions in the anxiety symptoms of individuals diagnosed with SUD. This paper provided support for the effectiveness of mindfulness-based cognitive intervention derived from the positive psychological severity symptoms of anxiety among individuals diagnosed with SUDs. The findings produced by this study can help modify the intervention and improve the effectiveness of future trials.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Cited by 1

Cites 8

and 3 more in the library

Related reading

Explore topics

Addiction Anxiety Meditation